US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
  • Biopharmaceuticals (232)
  • Diseases & Conditions (4574)
  • Drug Delivery (190)
  • Therapeutic Area (7211)
  • Vaccines (655)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Belarus Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... to behurt by these factors. We expect the Belarusian government to increase its focus on import substitutiongiven its balance of payments crisis, with negative implications for the pharmaceutical sector. Headline Expenditure Projections Pharmaceuticals: BYR10,223bn in ...  |  read more...
USD 1,295
Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019
6/24/2015 | published by: TechNavio - Infiniti Research Ltd.
... DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association (APA), PTSD is classified under anxiety disorders. PTSD can occur in individuals of any age, irrespective of ...  |  read more...
USD 2,500
Investigation Report on China Paclitaxel Market, 2010-2019
6/25/2015 | published by: China Research and Intelligence Co., Ltd.
... cancer and advanced ovarian cancer. As paclitaxel rapidly becomes popular in the clinic over the next 20 years, at present it is utilized in the treatment of advanced breast carcinoma, prostatic cancer, Kaposi‚Äôs sarcoma, head ...  |  read more...
USD 2,000
Investigation Report on China Olanzapine Market, 2010-2019
6/25/2015 | published by: China Research and Intelligence Co., Ltd.
... Mental Health, China-CDC, the number of cases of mental illnesses is more than 100 million, among which 16 million suffer from holergasia. Mental illness has surpassed cancer and become the biggest threat to human health, ...  |  read more...
USD 2,000
Investigation Report on China Sodium Hyaluronate Market, 2010-2019
6/25/2015 | published by: China Research and Intelligence Co., Ltd.
... the joint, protect cartilage of the joint, improve joint contracture and pathological articular fluid. Sodium hyaluronate eye drop is used for the treatment of dry eyes and mechanical lesion to corneal endothelium while sodium hyaluronate ...  |  read more...
USD 2,000
Investigation Report on China Levofloxacin Market, 2010-2019
6/25/2015 | published by: China Research and Intelligence Co., Ltd.
... market in China, anti-infectious drug has been the best-selling drug for many years, accounting for 30% of the total sales value. Quinolones, an up-rising antimicrobial, has increasingly attained attention around the world. As a levo ...  |  read more...
USD 2,000
Czech Republic Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... Exports are to see a rise in demand from tradingpartners based on our expectation of increasing generic penetration throughout Europe and demand forgenerics in general across emerging markets. We expect imports to be boosted by ...  |  read more...
USD 1,295
India Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... is driven by the low levels ofhealthcare funding provided by the government as it seeks to reduce budget deficit and prioritise othersectors such as infrastructure. Moreover, we highlight that improvements in healthcare access from theprogramme ...  |  read more...
USD 1,295
Global and Chinese Almotriptan (CAS 154323-57-6) Industry, 2015 Market Research Report
6/17/2015 | published by: Prof-Research
... Almotriptan industry with a focus on the Chinese market. The report provides key statistics on the market status of the Almotriptan manufacturers and is a valuable source of guidance and direction for companies and individuals ...  |  read more...
USD 3,000
Global and Chinese Spirulina Industry, 2015 Market Research Report
6/17/2015 | published by: Prof-Research
... with a focus on the Chinese market. The report provides key statistics on the market status of the Spirulina manufacturers and is a valuable source of guidance and direction for companies and individuals interested in ...  |  read more...
USD 3,000
Global and Chinese Enteral Feeding Pump Industry, 2015 Market Research Report
6/17/2015 | published by: Prof-Research
... the global Enteral Feeding Pump industry with a focus on the Chinese market. The report provides key statistics on the market status of the Enteral Feeding Pump manufacturers and is a valuable source of guidance ...  |  read more...
USD 3,000
Global and Chinese Betamethasone 21-Phosphate Disodium (CAS 151-73-5) Industry, 2015 Market Research Report
6/17/2015 | published by: Prof-Research
... state of the global Betamethasone 21-Phosphate Disodium industry with a focus on the Chinese market. The report provides key statistics on the market status of the Betamethasone 21-Phosphate Disodium manufacturers and is a valuable source ...  |  read more...
USD 3,000
Global and Chinese Betamethasone Dipropionate (CAS 5593-20-4) Industry, 2015 Market Research Report
6/17/2015 | published by: Prof-Research
... the global Betamethasone Dipropionate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Betamethasone Dipropionate manufacturers and is a valuable source of guidance and direction ...  |  read more...
USD 3,000
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... abroad. Over the long-term, domesticmanufacturers will increase their market share, with the government placing an increasing emphasis onachieving self-sufficiency in terms of pharmaceutical production. Headline Expenditure Projections Pharmaceuticals: SDG2.35bn (USD402mn) in 2014 to SDG2.65bn (USD433mn) ...  |  read more...
USD 1,295
United Kingdom Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... spending, for future business expansion potentialsto be met there needs to be a focus upon evolving current healthcare services while also containing costs. On a pharmaceutical front, this evolution needs to take place through the ...  |  read more...
USD 1,295
China Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... access through stronger medicalsubsidies and an expansion of insurance coverage. In addition, reforms in the pharmaceutical sector,including the removal of price caps, will shift the industry towards a market-based system that furtheraugments the commercial prospects. ...  |  read more...
USD 1,295
Cuba Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... cooperation with the island's pharmaceutical sector andJapanese investment in Cuba's healthcare system underscore the significant progress Cuba has achieved inrecent years. Therefore, Cuba will continue to offer unique commercial opportunities to foreign companieswho will benefit ...  |  read more...
USD 1,295
Ireland Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... fundamentals and Ireland's government policies to attractforeign investment in the pharmaceutical sector. Recent acquisitive trends are illustrated by ongoingmerger bids between Mylan, Perrigo and Teva, as well as Actavis' acquisition of Allergan, of which theoutcome ...  |  read more...
USD 1,295
Global Colorectal Cancer Drugs Market 2015-2019
6/17/2015 | published by: TechNavio - Infiniti Research Ltd.
... most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common ...  |  read more...
USD 3,000
Moldova Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... and GBP combined with the full force of Western sanctions against the Russian Economy,as well as the drop in global oil prices. Indeed, a sluggish road is ahead for market growth in Moldova. However, increased ...  |  read more...
USD 1,295
Morocco Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... innovative drugmakers to continueseeking opportunities in Morocco, particularly with recent updates to the intellectual property law thathighlights the country's commitment to improving the operating environment for multinationals. Headline Expenditure Projections Pharmaceuticals: MAD12.12bn (USD1.44bn) in 2014 ...  |  read more...
USD 1,295
Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis
6/15/2015 | published by: Market Intelligence & Consulting Institute
... high sugar and calorie intakes. Having a blood glucose meter is evidenced to help diabetes patients effectively control blood glucose levels, thereby reducing the risk of complications associated with diabetes. This report provides an overview ...  |  read more...
USD 2,000
TCR/CAR-T Therapies in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... is able to launch the first successful CAR-T therapy drug. In this regard, we have already witnessed the stellar results by Novartis and Penn University on CTL019 that left 92% of patients cancer-free in a ...  |  read more...
USD 2,985
IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... the MAPK signaling module and activate NFkB, they are synergistic and complement each other's activity. There are today 106 companies plus partners developing 103 IL-1 pathway targeting drugs in 407 developmental projects in cancer. In ...  |  read more...
USD 4,485
IL-3 Signaling Pathway in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... drugs in 1156 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 126 drugs. Il-3 Signaling Pathway In Oncology ...  |  read more...
USD 6,750
< prev 1    3  4  5  6  7  8  9  10